Exploiting complementary therapeutic strategies for the treatment of type II diabetes and prevention of its complications (Q73650157)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9278926%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Exploiting complementary therapeutic strategies for the treatment of type II diabetes and prevention of its complications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9278926%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

complementary therapy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9278926

13 November 2024

author name string

M. F. McCarty

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A9278926

13 November 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9278926

13 November 2024

publication date

1 August 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9278926%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

August 1997

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=9278926

full work available at URL

13 November 2024

https://api.elsevier.com/content/article/PII:S030698779790219X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0306-9877(97)90219-X

https://api.elsevier.com/content/article/PII:S030698779790219X?httpAccept=text/plain

13 November 2024

1 reference

https://api.crossref.org/works/10.1016/S0306-9877(97)90219-X

13 November 2024

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9278926%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

49

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9278926%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9278926%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

143-152

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9278926%20AND%20SRC:MED&resulttype=core&format=json

Lilly lecture 1987. The triumvirate: beta-cell, muscle, liver. A collusion responsible for NIDDM.

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Variations in insulin-stimulated glucose uptake in healthy individuals with normal glucose tolerance.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Plasma insulin responses to glucose and tolbutamide of normal weight and obese diabetic and nondiabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Blood glucose control and diabetic microvascular complications: long-term effects of near-normoglycaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Insulin and atheroma. 20-yr perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Insulin resistance--not hyperinsulinemia--is pathogenic in essential hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Acute hyperinsulinemia induces sodium retention and a blood pressure decline in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Insulin therapy induces antiatherogenic changes of serum lipoproteins in noninsulin-dependent diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Hemostatic concomitants of syndrome X

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Contribution of endogenous generation of endothelin-1 to basal vascular tone

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Elevated plasma endothelin in patients with diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Effect of a phorbol ester on immunoreactive endothelin-1 release from cultured porcine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Up-regulation of intracellular signalling pathways may play a central pathogenic role in hypertension, atherogenesis, insulin resistance, and cancer promotion--the 'PKC syndrome'

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

High density lipoproteins stimulate the production and secretion of endothelin-1 from cultured bovine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Correction of hyperglycemia with phlorizin normalizes tissue sensitivity to insulin in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Acute and chronic effects of hyperglycaemia on glucose metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Role of diet and exercise in the management of hyperinsulinemia and associated atherosclerotic risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

An improved assay for biologically active chromium

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Chromium picolinate increases membrane fluidity and rate of insulin internalization

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Composition and biological activity of chromium-pyridine carboxylate complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Dietary chromium supplementation with or without somatotropin treatment alters serum hormones and metabolites in growing pigs without affecting growth performance

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Supplemental-chromium effects on glucose, insulin, glucagon, and urinary chromium losses in subjects consuming controlled low-chromium diets

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Chromium Deficiency in Rats: a Syndrome Simulating Diabetes Mellitus with Retarded Growth

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Chromium Deficiency During Total Parenteral Nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Chromium deficiency, glucose intolerance, and neuropathy reversed by chromium supplementation, in a patient receiving long-term total parenteral nutrition

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

The effect of chromium on established atherosclerotic plaques in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

The action of chromium on serum lipids and on atherosclerosis in cholesterol-fed rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Chromium and cholesterol-induced atherosclerosis in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Effects of potassium chromate on atherosclerosis prevention and regression in rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Chromium deficiency as a factor in atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Low plasma Chromium in patients with coronary artery and heart diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Effects of chromium supplementation on serum high-density lipoprotein cholesterol levels in men taking beta-blockers. A randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Pharmacologic doses of vitamin E improve insulin action in healthy subjects and non-insulin-dependent diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Improved insulin response and action by chronic magnesium administration in aged NIDDM subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Effect of combined supplementation with alpha-tocopherol, ascorbate, and beta carotene on low-density lipoprotein oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Differential Effects of Megavitamin E on Prostacyclin and Thromboxane Synthesis in Streptozotocin-Induced Diabetic Rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Vitamin E consumption and the risk of coronary disease in women

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Vitamin E consumption and the risk of coronary heart disease in men.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Magnesium interrelationships in ischemic heart disease: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Magnesium in coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Effect of magnesium on blood pressure.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Complementary vascular-protective actions of magnesium and taurine: a rationale for magnesium taurate

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Magnesium: Nature's physiologic calcium blocker

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Regression of atherosclerosis. A role for calcium antagonists.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Hypomagnesaemia in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Magnesium and insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Potentiation of the actions of insulin by taurine

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Hypoglycemic properties of taurine: not mediated by enhanced insulin release.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Effects of increased adrenomedullary activity and taurine in young patients with borderline hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Usefulness of taurine in chronic congestive heart failure and its prospective application

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Taurine modulates platelet aggregation in cats and humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

The protective effects of taurine on hypoxia (performed in the absence of glucose) and on reoxygenation (in the presence of glucose) in guinea-pig heart

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

The effects of taurine on atherosclerosis development in cholesterol-fed rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Decrease in postprandial insulin and glucose concentrations by guar and pectin

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Guar gum improves insulin sensitivity, blood lipids, blood pressure, and fibrinolysis in healthy men

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Effect of metformin on carbohydrate and lipoprotein metabolism in NIDDM patients

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Effect of metformin on postprandial lipemia in patients with fairly to poorly controlled NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Effect of metformin on insulin-stimulated glucose turnover and insulin binding to receptors in type II diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Treating insulin resistance in hypertension with metformin reduces both blood pressure and metabolic risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Metabolic and hemodynamic effects of metformin and glibenclamide in normotensive NIDDM patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Effect of metformin on lipid metabolism in the rabbit aortic wall

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Metformin action on lipid metabolism in lesions of experimental aortic atherosclerosis of rabbits

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Comparison of chlorpropamide and metformin treatment on weight and blood-glucose response of uncontrolled obese diabetics

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Effect of chromium picolinate on growth and serum and carcass traits of growing-finishing pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

New Pharmacological Approaches to Therapy of NIDDM

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Effect of pioglitazone on insulin receptors of skeletal muscles from high-fat-fed rats

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Effect of chronic hyperglycemia on in vivo insulin secretion in partially pancreatectomized rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Therapeutic comparison of metformin and sulfonylurea, alone and in various combinations. A double-blind controlled study.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Controversy Over Study of Diabetes Drugs Continues for Nearly a Decade

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

The sulphonylurea receptor may be an ATP-sensitive potassium channel.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Inhibition by sulphonylureas of vasorelaxation induced by K+ channel activators in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

The pharmacology of ATP-sensitive K+ channels in the heart

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Hyperpolarizing vasodilators activate ATP-sensitive K+ channels in arterial smooth muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Hypoxic dilation of coronary arteries is mediated by ATP-sensitive potassium channels

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

ATP-regulated K+ channels in cardiac muscle

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Direct effect of hypoglycemic sulphonylureas on the cardiovascular system of dogs

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Divergent cardiac effects of the first and second generation hypoglycemic sulfonylurea compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Inhibition by glibenclamide of the vasorelaxant action of cromakalim in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

ATP-dependent potassium channels of muscle cells: their properties, regulation, and possible functions

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Sulfonylureas in NIDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS0306-9877%2897%2990219-X

7 January 2021

Supplementation with vitamin E but not beta-carotene in vivo protects low density lipoprotein from lipid peroxidation in vitro. Effect of cigarette smoking

54

1 reference

https://api.crossref.org/works/10.1016/S0306-9877(97)90219-X

Magnesium ions and contraction of vascular smooth muscles: relationship to some vascular diseases

13 November 2024

61

1 reference

https://api.crossref.org/works/10.1016/S0306-9877(97)90219-X

The role of magnesium in the prevention and control of hypertension

13 November 2024

63

1 reference

https://api.crossref.org/works/10.1016/S0306-9877(97)90219-X

Decreased urinary taurine in essential hypertension

13 November 2024

73

1 reference

https://api.crossref.org/works/10.1016/S0306-9877(97)90219-X

13 November 2024

The heart in diabetes

78

1 reference

https://api.crossref.org/works/10.1016/S0306-9877(97)90219-X

Antiarrhythmic action of taurine

13 November 2024

79

1 reference

https://api.crossref.org/works/10.1016/S0306-9877(97)90219-X

The effect of sulphonylurea therapy on the outcome of coronary heart diseases in diabetic patients

13 November 2024

114

1 reference

https://api.crossref.org/works/10.1016/S0306-9877(97)90219-X

Sulfonylurea signal transduction

13 November 2024

116

1 reference

https://api.crossref.org/works/10.1016/S0306-9877(97)90219-X

The effect of tolbutamide on blood pressure

13 November 2024

122

1 reference

https://api.crossref.org/works/10.1016/S0306-9877(97)90219-X

13 November 2024

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9278926%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference